Not every epoxy that bonds well is suitable for medical device assembly. The chemical, biological, and regulatory requirements that distinguish a medical-grade adhesive from a standard industrial adhesive are not simply a matter of labeling — they reflect fundamental differences in raw material selection, formulation purity, testing protocols, and documentation that industrial adhesives never need to satisfy. A device manufacturer who uses an industrial epoxy because it meets the lap shear specification and ignores the biocompatibility, sterilization resistance, and traceability requirements faces regulatory exposure, product liability, and the practical problem of a submitted 510(k) with no biocompatibility data package behind the adhesive choice.
The Biocompatibility Requirement
The primary distinction of a medical-grade epoxy is demonstrated biocompatibility — evidence that the material does not cause harm to living tissue under the conditions of patient contact anticipated in the device design. The standard framework for biocompatibility evaluation is ISO 10993, which defines a family of tests covering cytotoxicity, sensitization, irritation, systemic toxicity, genotoxicity, and others, with the applicable test battery selected based on the nature and duration of patient contact.
For a non-contacting device — one where the adhesive is inside a sealed housing and never contacts the patient directly — the biocompatibility requirement may be minimal or addressed by the overall device design. For a skin-contact wearable device, the adhesive used in the housing construction must be evaluated for ISO 10993-10 sensitization and ISO 10993-23 irritation. For a device with a fluid pathway where process fluids contact the adhesive — a blood analyzer flow cell, a ventilator flow manifold — the adhesive must be evaluated for extractables and leachables under ISO 10993-12 and -17, confirming that the chemical entities that leach from the adhesive into the fluid stream are below toxicologically derived thresholds.
Medical-grade epoxy formulations carry this testing data — performed on the specific formulated product by an accredited laboratory, reported in a format suitable for inclusion in a device regulatory submission. Industrial adhesives do not carry equivalent documentation; their raw materials may or may not be bio-compatible individually, and no system-level biocompatibility package exists for a device manufacturer to reference.
Raw Material Selection and Formulation Purity
The biocompatibility of a cured epoxy depends on the specific chemical entities present in the cured network and in the residual unreacted chemistry. Medical-grade epoxy formulations are manufactured from raw materials selected for their known safety profiles, and formulated to minimize residual unreacted components after cure.
Bisphenol-A (BPA) content is one consideration: BPA, a component in many standard epoxy resins, has documented endocrine activity at sufficient concentrations, and regulatory authorities in several jurisdictions have restricted its use in food-contact and medical applications. Medical-grade epoxies may use non-BPA resin systems or may demonstrate that BPA migration from the cured product is below established thresholds.
Catalysts and accelerators used in epoxy cure can generate leachable residues. Tertiary amine accelerators, imidazole catalysts, and certain anhydride hardeners leave residual chemistry in the cured network that can extract under aqueous or physiological conditions. Medical formulations use hardener systems that minimize these residuals or that have established safety profiles for the anticipated contact conditions.
Diluents, thinners, and flow additives used to modify viscosity in industrial formulations are often volatile or extractable compounds. Medical-grade formulations minimize these additives or use functionally reactive diluents that incorporate into the crosslinked network during cure, reducing the pool of extractable low-molecular-weight species.
For biocompatibility documentation and raw material safety profiles for specific Incure formulations, Email Us — Incure can provide the data needed for medical device regulatory submissions.
Sterilization Compatibility
Medical devices in patient contact applications must be sterile — and the sterilization process is often more chemically aggressive than the device’s service environment. An epoxy adhesive that performs adequately in service but degrades during sterilization creates failures that appear at the worst possible time: after final device assembly and testing, during the sterilization step before distribution.
Autoclave sterilization (steam, 121°C to 134°C) requires the adhesive to survive repeated exposure to steam and high temperature. Standard epoxy adhesives with Tg near 80°C will soften and creep during autoclave cycles; medical-grade epoxies for autoclave-compatible devices are formulated with Tg above 140°C to maintain properties through repeated sterilization cycles.
Gamma radiation sterilization generates free radicals in the epoxy network that can cause chain scission or additional crosslinking, depending on the chemistry. Gamma-stable formulations are characterized for property retention after the specified dose (typically 25 to 50 kGy).
Ethylene oxide (EtO) sterilization exposes the device to EtO gas at moderate temperature. The epoxy must not absorb and retain EtO at levels that would be toxic to the patient; residual EtO and its reaction products (ethylene glycol, ethylene chlorohydrin) must degas to below regulatory limits before device release.
Traceability and Lot Documentation
Medical device quality systems under ISO 13485 require traceability of all materials used in device production. The adhesive used in every production lot must be traceable to a specific lot of adhesive with documented properties — not just the product name, but the specific lot number, its certificate of analysis confirming tested properties, and the corresponding biocompatibility data.
Medical-grade epoxy suppliers provide lot-specific certificates of analysis covering viscosity, mixing ratio, cure characteristics, and relevant mechanical properties. The lot number and CoA are documented in the device production record so that if a quality issue arises, the specific material lot used in any affected device can be identified.
This traceability requirement is not satisfied by using an industrial adhesive, even one that happens to perform adequately in the application. Industrial adhesives do not carry the lot documentation structure that a medical quality system requires, and the device manufacturer cannot demonstrate material traceability without it.
Contact Our Team to discuss medical-grade epoxy selection, biocompatibility documentation, sterilization compatibility data, and ISO 13485 lot traceability for your specific device assembly application.
Visit www.incurelab.com for more information.